Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback

David Galarneau, MD

David Galarneau, MD is board certified in psychiatry and addiction medicine and has been at Ochsner Health since July 2006. He is the Vice Chair and Director of Research of the Department of Psychiatry, as well as the Medical Director of Quality for the Behavioral Health Service Line. He is also the Director of the Undergraduate Medical Education Program in Psychiatry and the Head of the Edgar Burns Society at the Ochsner Clinical School. On the clinical side, he is the Medical Director of the Ochsner Recovery Program and the Addiction Psychiatry Consultation Service. Additionally, he is a certified evaluator for the ADHD Therapeutic Use Exemptions Program of the National Football League.

Dr. Galarneau completed his residency training in psychiatry at the New York-Presbyterian Hospital Payne Whitney Clinic, where he served as chief resident. He completed medical school at Weill Medical College of Cornell University and received a BS in biology and BA in philosophy from Rensselaer Polytechnic Institute, where he finished with the highest academic record in his class.

Dr. Galarneau is a distinguished fellow of the American Psychiatric Association, a distinguished fellow of the Louisiana Psychiatric Medical Association, and a fellow of the American Society of Addiction Medicine. He serves on two national committees: the Council on Quality Care of the American Psychiatric Association and the NIDA Young Investigator Travel Award Subcommittee of the American Society of Addiction Medicine.

Dr. Galarneau currently resides in New Orleans with his wife Ashley and children Finn (18), Daniel (7), and Mary Frances (4). Finn will be headed to the University of Chicago in the fall.

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2025 Ochsner Clinic Foundation

Powered by HighWire